HolderBook

TEVA PHARMACEUTICAL INDS LTD (TEVA)

Institutional ownership reported to the SEC as of Q3 2026, across 32 quarters.

2
Reporting holders
$364.6K
Reported value
0.0%
Calls
0.0%
Puts
-679
Holder change

Calls and puts are the parts of reported value carried in derivative lines rather than shares, and they point in opposite directions: a manager holding calls is positioned for the security, one holding puts against it - or hedging shares they already own, which is why index funds carry so many. Most sites add the two together and report one figure, which averages away the only interesting part.

Holders

Download these holders as CSV

FilerValueShares Their book Held Change
CACTI ASSET MANAGEMENT LLC$351.3K9,0000.02%32qHELD
Byrne Asset Management LLC$13.4K3400.01%10q-22.7%-$3.9K

Tender offers and delisting

Schedules TO, 13E-3 and 14D-9 and Form 25 filed in the last 180 days. Price a share is read from the filing itself where it states one plainly; a marker means we found no figure we could stand behind, and the reason is on it.

FiledWhatFiled byPrice a shareSource
2026-09-14Delisting notice from the exchangeNEW YORK STOCK EXCHANGE LLC-filing

What the company announced

Form 8-K filings from the last 120 days, showing only the items worth a reader's attention. Earnings releases, exhibit attachments and general disclosures are filed constantly and are left out. Filed is when the SEC received it; event is the date the company says the thing happened.

FiledEvent dateWhatSource
2026-09-162026-09-16Material agreement enteredfiling

What the insiders did

Open market purchases and sales reported on Form 4 in the last 180 days. Grants, option exercises and shares surrendered to cover tax are left out: they are compensation rather than a decision to buy or sell. Where a broker filled one order in tranches the lines are summed, because it was one decision.

Officers and directors

DateInsiderRoleSideSharesValue
2026-09-18MIGNONE ROBERTODirectorSold367,600$14.4M
2026-05-14Kalif Eliyahu SharonEVP, Chief Financial OfficerSold153,251$5.5M
2026-05-01Sabag MarkSee "Remarks"Sold144,180$5.0M
2026-06-11Kalif Eliyahu SharonEVP, Chief Financial OfficerSold106,563$3.6M
2026-05-14Lippman EvanEVP, Business DevelopmentSold41,658$1.5M ×2
2026-05-05Daniell RichardEVP, Europe CommercialSold30,000$1.1M
2026-08-03Hughes Eric ASee "Remarks"Sold25,578$892.1K
2026-04-30Fox ChristineEVP, U.S. CommercialSold21,258$750.6K
2026-08-17Lippman EvanEVP, Business DevelopmentSold18,600$680.3K
2026-06-03Shields MatthewEVP, Global OperationsSold16,195$532.3K
2026-08-03Jover PlacidSee "Remarks"Sold12,827$447.4K
2026-05-06Weiss AmirChief Accounting OfficerSold10,679$384.4K

Quarter by quarter

Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.

QuarterHoldersValue SharesNewAdded TrimmedOptions
Q3 20262$364.6K9,3400010.0%
Q2 2026681$26.9B761,317,464772731864.6%
Q1 2026656$21.3B675,124,099832231875.3%
Q4 2025649$23.3B688,012,2291091951868.0%
Q3 2025565$15.9B730,833,244731741757.4%
Q2 2025548$13.4B744,903,348461961616.7%
Q1 2025567$11.9B715,634,690661901747.4%
Q4 2024594$15.8B666,020,546671871857.1%
Q3 2024549$12.1B637,996,776681851646.3%
Q2 2024537$10.7B614,595,874811801527.0%
Q1 2024490$8.9B587,250,002711691247.0%
Q4 2023453$6.5B588,598,311511231375.3%
Q3 2023438$6.5B589,600,506501241277.0%
Q2 2023432$4.1B499,241,324451211367.6%
Q1 2023438$5.4B561,082,872581131399.1%
Q4 2022424$5.7B561,422,2364111913811.6%
Q3 2022423$5.1B560,505,6704113013112.0%
Q2 2022452$4.5B506,845,1275112512815.5%
Q1 2022434$5.6B514,832,9114413210813.5%
Q4 2021438$5.0B517,565,8744112012517.4%
Q3 2021423$5.7B527,457,5103311613610.6%
Q2 2021435$6.1B561,305,787361231349.4%
Q1 2021451$7.3B574,185,499511261326.9%
Q4 2020450$6.2B579,370,2434412114810.0%
Q3 2020443$5.5B568,047,665451201417.5%
Q2 2020460$7.8B581,189,783641241388.5%
Q1 2020457$5.7B555,626,6158814411012.5%
Q4 2019434$6.7B592,066,2845212113513.9%
Q3 2019430$4.7B595,217,2114711613712.7%
Q2 2019453$6.8B653,712,5175215813411.3%
Q1 2019526$11.2B671,410,390441511805.7%
Q4 2018563$11.8B699,763,34177158.3%